
---
title: Anthrax
markmap:
  colorFreezeLevel: 6
---

## Anthrax
- Organism: *Bacillus anthracis*
  - Gram-positive rod
  - Spore-forming (central, non-swelling)
  - Non-motile
  - Capsule (Poly-D-glutamic acid)
- Virulence Factors
  - Toxins (pXO1 plasmid)
    - Protective Antigen (PA)
    - Lethal Factor (LF)
    - Edema Factor (EF)
    - Lethal Toxin (LT = PA + LF)
    - Edema Toxin (ET = PA + EF)
  - Capsule (pXO2 plasmid)
- Transmission
  - Spores (Key)
  - Cutaneous (contact with infected animal products)
  - Inhalation (aerosolized spores)
  - Gastrointestinal (ingestion of contaminated meat)
  - Injection (rare, drug users)
- Clinical Forms
  - **Cutaneous** (Most common)
    - Painless papule -> vesicle -> ulcer -> Black Eschar (Malignant Pustule)
    - Edema
  - **Inhalation** (Most severe, high mortality)
    - Biphasic: Flu-like -> rapid deterioration
    - Hemorrhagic Mediastinitis
    - Mediastinal widening on CXR (Classic sign)
  - Gastrointestinal (Rare)
  - Injection (Rare)
- Diagnosis
  - Clinical suspicion
  - Microscopy: Gram stain, McFadyean reaction (pink capsule around purple rods)
  - Culture: Non-hemolytic, Medusa Head colonies on blood agar
  - PCR (Rapid & Sensitive)
  - Serology (ELISA)
  - Imaging (CXR/CT for inhalation form)
- Treatment
  - Antibiotics (Early crucial)
    - Ciprofloxacin or Doxycycline (First-line)
    - Combination therapy for severe/inhalation/meningeal (add Clindamycin, Rifampicin, Meropenem)
  - Antitoxins (Severe cases, inhalation, systemic)
    - Raxibacumab (Monoclonal antibody)
    - Obiltoxaximab (Monoclonal antibody)
    - Anthrax Immune Globulin (AIG)
- Prevention
  - Animal Vaccination
  - Human Vaccine (BioThrax - for high-risk groups, PEP)
  - Post-exposure Prophylaxis (PEP): Ciprofloxacin/Doxycycline for 60 days + Vaccine (if indicated)
- Bioterrorism Agent (Category A)
  - Weaponized spores for inhalation
- INICET Buzzwords
  - Bacillus anthracis
  - Spores
  - Poly-D-glutamic acid capsule
  - PA, LF, EF (Lethal Toxin, Edema Toxin)
  - Malignant Pustule
  - Black Eschar
  - Wool Sorters' Disease
  - Hemorrhagic Mediastinitis
  - Mediastinal widening
  - McFadyean reaction
  - Medusa Head colonies
  - Ciprofloxacin
  - Doxycycline
  - Raxibacumab, Obiltoxaximab
  - PEP (Post-exposure prophylaxis)
  - Bioterrorism (Category A)
